BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1392 related articles for article (PubMed ID: 9808056)

  • 1. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
    de Wynter EA; Nadali G; Coutinho LH; Testa NG
    Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
    Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
    Opie TM; Shields LE; Andrews RG
    Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
    Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
    Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow.
    Kinniburgh D; Russell NH
    Bone Marrow Transplant; 1993 Nov; 12(5):489-94. PubMed ID: 7507766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of bone marrow stem cell.
    Terstappen LW; Huang S
    Blood Cells; 1994; 20(1):45-61; discussion 61-3. PubMed ID: 7527679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
    Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
    Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
    Sutherland DR; Yeo EL; Stewart AK; Nayar R; DiGiusto R; Zanjani E; Hoffman R; Murray LJ
    Exp Hematol; 1996 Jun; 24(7):795-806. PubMed ID: 8647230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
    Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
    Tian H; Huang S; Gong F; Tian L; Chen Z
    Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine stromal cell line HESS-5 maintains reconstituting ability of Ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood.
    Shimakura Y; Kawada H; Ando K; Sato T; Nakamura Y; Tsuji T; Kato S; Hotta T
    Stem Cells; 2000; 18(3):183-9. PubMed ID: 10840071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer.
    Kadereit S; Deeds LS; Haynesworth SE; Koc ON; Kozik MM; Szekely E; Daum-Woods K; Goetchius GW; Fu P; Welniak LA; Murphy WJ; Laughlin MJ
    Stem Cells; 2002; 20(6):573-82. PubMed ID: 12456965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
    Harvey K; Higgins N; Akard L; Chang Q; Jansen J; Thompson J; Dugan M; Rizzo MT; English D
    J Hematother; 1997 Jun; 6(3):243-52. PubMed ID: 9234179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.